Ozempic & NAION: EU Safety Panel Continues Probe Into Link With Eye Condition

 
• By Neena Brizmohun

The European Medicines Agency says it will take appropriate measures to update the Ozempic’s package leaflet if new evidence arises.

Female hands holding an insulin pen. Ozempic Insulin injection pen or insulin cartridge pen for diabetics
The EMA is investigating whether Ozempic increases the risk of developing a rare eye condition (Shutterstock)

More from Drug Safety

More from Geography